Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
03/2005
03/17/2005CA2536967A1 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
03/17/2005CA2535744A1 Piperazines as oxytocin agonists
03/16/2005EP1514942A1 Method of searching substane having antidiabetic activity
03/16/2005EP1514552A1 Novel fused imidazole derivative
03/16/2005EP1513844A1 Novel interleukin-1 beta converting enzyme inhibitors
03/16/2005EP1513843A1 Pyrazolopyrimidines and the use thereof for controlling harmful organisms
03/16/2005EP1513842A1 Substituted hexahydropyrrolo (1,2-a)pyrazines, octahydropyrido(1,2-a)pyrazines and decahydropyrazino(1,2-a)azepines
03/16/2005EP1513820A2 Compounds, compositions, and methods
03/16/2005EP1513537A1 Substituted porphyrins
03/16/2005EP1513536A1 Use of compounds that stimulate cgmp
03/16/2005EP1399436B1 Oxytocin agonists
03/16/2005EP1362081B1 Acid pigment dispersants and pigment preparations
03/16/2005EP0929553B1 Pyrimidine derivatives and processes for the preparation thereof
03/16/2005EP0869966B1 Prodrugs of thrombin inhibitors
03/16/2005EP0812308B1 Method for synthesis of aryl difluoromethyl ethers and the like
03/16/2005EP0758324B1 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
03/16/2005CN1596258A Adenosine A2a receptor antagonists
03/16/2005CN1596257A Novel crystalline compound
03/16/2005CN1596253A Spiro-hydantoin compounds useful as anti-inflammatory agents
03/16/2005CN1596251A Piperazine derivatives having SST1 antagonistic activity
03/16/2005CN1596247A Lactam derivatives as antagonists for human 11CBY receptors
03/16/2005CN1596111A Methods and compositions for ameliorating the undesirable effects of chemotherapy
03/16/2005CN1193034C Process for preparing ferriporphyrin sodium salt
03/16/2005CN1192777C Use of a indolequinoxaline compound for preparing multiple sclerosis a drug
03/15/2005US6867300 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
03/15/2005US6867230 Antibacterial and antiprotozoal agents
03/15/2005US6867211 Fused nitrogen biheterocyclic derivatives; immunomodulaters; inhibiting cytokine release
03/15/2005US6867208 Vitronectin receptor antagonists, their preparation and their use
03/15/2005US6867198 Agents and methods for the treatment of proliferative diseases
03/15/2005CA2246595C Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones
03/15/2005CA2146852C New substituted pyrazole derivatives, processes for their preparation and their use as herbicides
03/15/2005CA2063671C Aminoguanidines
03/10/2005WO2005022650A1 Field effect transistor and method of manufacturing the same
03/10/2005WO2005022649A1 Field effect transistor and method of manufacturing the same
03/10/2005WO2005021658A1 Tetraazaporphyrin compound
03/10/2005WO2005021555A1 Bicyclic piperazine compound and use thereof
03/10/2005WO2005021551A1 Substituted heterocyclic compounds and methods of use
03/10/2005WO2005021550A1 Bicyclic pyrazole derivative
03/10/2005WO2005021545A1 IMIDAZO[1,5-a]PYRIDINE OR IMIDAZO[1,5-a]PIPERIDINE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF MEDICAMENT AGAINST 5-HT2A RECEPTOR-RELATED DISORDERS
03/10/2005WO2005021533A1 Substituted isoquinoline derivatives and methods of use
03/10/2005WO2005021515A2 Inhibitors of phosphodiesterase type-iv
03/10/2005WO2005021500A1 Cyclic derivatives as modulators of chemokine receptor activity
03/10/2005WO2005021495A2 Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
03/10/2005WO2005021025A2 MODULATION OF β-CATENIN/TCF ACTIVATED TRANSCRIPTION
03/10/2005WO2005020899A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity
03/10/2005WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/10/2005WO2004112793B1 Guanidino-substituted quinazolinone compounds as mc4-r agonists
03/10/2005WO2004085661A3 Process to chiral beta-amino acid derivatives
03/10/2005WO2004082613A3 2,4-diamino-5-[5’-substituted-benzyl] pyrimidines and 2,4-diamino-6-[5’-substituted-benzyl] quinazolines
03/10/2005WO2004078761A8 Enantiomerically pure cilazapril,process for preparation
03/10/2005US20050054851 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases
03/10/2005US20050054849 Coordination sites of four nitrogen-containing groups of of imino, amido and amino groups, and has the nitrogen atoms of the four nitrogen-containing groups as coordinating atoms in one plane; metal complex assembly; acceptor and a donor interacting with each other; nanostructure; semiconductors
03/10/2005US20050054704 Derivatives of [6,7-dihydro-5H- Imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide
03/10/2005US20050054703 Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide
03/10/2005US20050054697 useful for the treatment or prophylaxis of bacterial infections in mammals
03/10/2005US20050054672 Quinolinone derivatives
03/10/2005US20050054661 Irritable bowel disorders; anxiolytic agents; antidepressants
03/10/2005US20050054658 4-Cycloalkylaminopyrazolo pyrimidine NMDA/NR2B antagonists
03/10/2005US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression
03/10/2005US20050054649 Probes for detecting the chaperone protein related to disease in biological samples; therapeutic treatment of cancer, autoimmune disease, inflammation, neurodegenerative disease, stroke, heart diseases
03/10/2005US20050054648 For therapy of cancer, including of breast neoplasma, endometrial cancer, colon cancer, and neck squamous cell carcinoma
03/10/2005US20050054645 Aids therapy; side effect reduction
03/10/2005US20050054644 Hydrolytically-resistant boron-containing therapeutics and methods of use
03/10/2005US20050054635 Therapy , prevention of obsessive-complusive disorders; antidepressants; anxiety; schizophrenia; eating disorders; obesity; antiepileptic agents central nervous system disorders; sleep disorders
03/10/2005US20050054634 Azepinoindole derivatives as pharmaceutical agents
03/10/2005US20050054631 Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP)
03/10/2005US20050054627 Cyclic derivatives as modulators of chemokine receptor activity
03/10/2005US20050054626 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
03/10/2005CA2537364A1 Imidazo[1,5-a]pyridine or imidazo[1,5-a]piperidine derivatives and their use for the preparation of medicament against 5-ht2a receptor-related disorders
03/10/2005CA2537185A1 Inhibitors of phosphodiesterase type-iv
03/10/2005CA2537099A1 Modulation of .beta.-catenin/tcf activated transcription
03/10/2005CA2536786A1 Substituted heterocyclic compounds and methods of use
03/10/2005CA2536378A1 Rifamycin analogs and uses thereof
03/10/2005CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/09/2005EP1512688A1 Use of K-252a derivatives for the treatment of Parkinson's disease
03/09/2005EP1512687A1 Piperazines as oxytocin agonists
03/09/2005EP1511751A1 Pyrazolo[1,5-a]pyrimidine compounds as antiviral agents
03/09/2005EP1511749A1 Novel interleukin-1beta converting enzyme inhibitors
03/09/2005EP1511492A2 Protease inhibitors
03/09/2005EP1370549A4 Methods for the preparation of mirtazapine intermediates
03/09/2005EP1057814B1 Tetrahydrobenzindole derivatives
03/09/2005EP0869792B1 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
03/09/2005EP0817627B1 Protein kinase c inhibitors
03/09/2005CN1592748A Separation of regioisomers of metal phthalocyanines
03/09/2005CN1592747A Diazabicyclo alkane derivatives with NK1 antagonistic activity
03/09/2005CN1592743A Inhibitors of glycogen synthase kinase 3
03/09/2005CN1592738A Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition
03/09/2005CN1592624A Substituted-triazolopyrimidines as anticancer agents
03/09/2005CN1592619A Pyranoindazoles and their use for the treatment of glaucoma
03/09/2005CN1590375A TNF-alpha prodn. inhibitors
03/09/2005CN1590374A TNF-alpha prodn. inhibitors
03/09/2005CN1589788A Modulating multiple lineage kinase proteins
03/09/2005CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds
03/09/2005CN1192009C Soluble chromophore containing solubilizing group easy to be removed
03/09/2005CN1191884C High surface microporous active materials TIQ-6 and METIQ-6 in oxidation reactions
03/08/2005US6864259 Antibacterial agents
03/08/2005US6864257 Usable as tranquillisers and hypnotics
03/08/2005US6864250 N-acylated lipophilic amino acid derivatives
03/08/2005US6864103 Such as hydroxyisophthamidylamide-based bidentate ligands; bioavailiable probes for use in immunoassay
03/08/2005CA2153239C 5-alkoxy[1,2,4]triazolo[1,5-c]pyrimidine-2(3h)-thione compounds and their use in the preparation of 2,2'-dithiobis(5-alkoxy[1,2,4]triazolo[1,5-c]-pyrimidine) and 2-chlorosulfonyl-5-alkoxy[1,2,4]triazolo[1,5-c]pyrimidine compounds
1 ... 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 ... 573